Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

While many children with leukemia experience good outcomes on modern therapies, there are a large number of children who still relapse and die of their disease. Using new methods, Dr. Willman identified a new form of leukemia, called Ph-like ALL, which has a variety of gene mutations which code for enzymes. Currently, drugs that inhibit these enzymes are available for clinical trials. Dr. Willman is testing these drugs in children with high risk leukemia. This research aims to extend Dr. Willman's current studies to include children with standard risk leukemia in order to also improve their chances of survival.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This grant helps provide necessary resources to increase enrollment in early phase clinical trials for neuroblastoma patients, and support the development of a new MIBG Therapy program to treat neuroblastoma.

This grant funds resources to bring together two different medical groups and multiple pediatric cancer doctors to ensure that more kids in Northern Nevada can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant provides resources to establish a new MIBG therapy program to treat neuroblastoma, an aggressive childhood cancer which can be difficult to treat. This treatment has been shown to help children with relapsed neuroblastoma and is now being used in newly diagnosed high risk patients.

This grant helps provide necessary resources to support the Survivorship Clinic, and to study, through increased clinical trial enrollment, the late effects of recently treated children.

This grant funds a nurse navigator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel at the clinic in Colorado Springs to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant provides resources to help build an AYA Survivorship Program, to ensure that more adolescents and young adults can be treated on clinical trials, and to provide survivorship planning.

This grant provides resources to help further develop international collaborative clinical and epidemiology research studies between the Children's Oncology Group and institutions across South America. GALOP members in Argentina, Brazil, Chile and Uruguay will ensure access to clinical trials, often a child's best hope for a cure.

This grant provides resources to expand the Pediatric Brain and Spinal Cord Tumor program and enhance research.